Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Jun 17, 2026
Purchase
Shares
239,759
Price
$0.04
Total Value
$10.69K
Shares Held After
93,629,319
% of Holdings
0.3%
Jun 16, 2026
Purchase
Shares
20,000
Price
$7.90
Total Value
$157.99K
Shares Held After
756,000
% of Holdings
2.6%

NeuroSense Therapeutics Ltd. (NRSN)

Ben-Noon Alon — Chief Executive Officer
Jun 16, 2026
Purchase
Shares
250,000
Price
$0.80
Total Value
$200.00K
Shares Held After
4,534,233
% of Holdings
5.5%

NeuroSense Therapeutics Ltd. (NRSN)

Eisenberg Or — Chief Financial Officer
Jun 16, 2026
Purchase
Shares
250,000
Price
$0.80
Total Value
$200.00K
Shares Held After
1,504,050
% of Holdings
16.6%
Jun 16, 2026
Purchase
Shares
2,836
Price
$2.64
Total Value
$7.49K
Shares Held After
972,170
% of Holdings
0.3%
Jun 16, 2026
Purchase
Shares
124,893
Price
$8.89
Total Value
$1.11M
Shares Held After
16,763,043
% of Holdings
0.7%
Jun 15, 2026
Purchase
Shares
96,000
Price
$0.04
Total Value
$4.32K
Shares Held After
93,389,560
% of Holdings
0.1%

Ocugen, Inc. (OCGN)

Johnson-Greene Treerita Essalima — Chief Financial Officer
Jun 15, 2026
Purchase
Shares
21,000
Price
$1.23
Total Value
$25.83K
Shares Held After
521,000
% of Holdings
4.0%
Jun 15, 2026
Purchase
Shares
1,000
Price
$10.19
Total Value
$10.19K
Shares Held After
17,592
% of Holdings
5.7%
Jun 15, 2026
Purchase
Shares
15,414
Price
$8.99
Total Value
$138.57K
Shares Held After
16,638,150
% of Holdings
0.1%
Jun 15, 2026
Purchase
Shares
2,067
Price
$2.22
Total Value
$4.59K
Shares Held After
19,198
% of Holdings
10.8%
Jun 15, 2026
Purchase
Shares
2,465
Price
$2.22
Total Value
$5.47K
Shares Held After
12,435
% of Holdings
19.8%

Processa Pharmaceuticals, Inc. (PCSA)

SKIBSTED RUSSELL — Chief Financial Officer
Jun 15, 2026
Purchase
Shares
2,654
Price
$2.22
Total Value
$5.89K
Shares Held After
13,412
% of Holdings
19.8%

Immuneering Corp (IMRX)

Hall Brett Matthew — CHIEF SCIENTIFIC OFFICER
Jun 15, 2026
Purchase
Shares
6,035
Price
$4.15
Total Value
$25.05K
Shares Held After
382,531
% of Holdings
1.6%

Processa Pharmaceuticals, Inc. (PCSA)

Lin Patrick — Chief Business - Strategy Off
Jun 15, 2026
Purchase
Shares
1,831
Price
$2.22
Total Value
$4.06K
Shares Held After
11,007
% of Holdings
16.6%

Processa Pharmaceuticals, Inc. (PCSA)

Guy Wendy — Chief Administrative Officer
Jun 15, 2026
Purchase
Shares
2,118
Price
$2.22
Total Value
$4.70K
Shares Held After
11,958
% of Holdings
17.7%
Version: v26.5.2